Bioventus (BVS) Restructuring Costs (2020 - 2026)

Bioventus' Restructuring Costs history runs 6 years deep, the most recent figure standing at $454000.0 for Q1 2026.

• Quarterly Restructuring Costs changed N/A year-over-year to $454000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $402000.0 (up 873.08% YoY) and the FY2025 annual result came in at $2.2 million, up 4398.08% from the prior year.
• Restructuring Costs was $454000.0 for Q1 2026 at Bioventus, up from -$52000.0 in the prior quarter.
• Across five years, Restructuring Costs topped out at $4.6 million in Q4 2022 and bottomed at -$71000.0 in Q4 2023.
• A 4-year average of $802100.0 and a median of $514500.0 in 2022 frame the typical range for Restructuring Costs.
• Annual changes were most pronounced in 2022 — Restructuring Costs surged 570.54% — and 2023, when it tumbled 104.52%.
• Bioventus' Restructuring Costs stood at $4.6 million in 2022, then plunged by 101.54% to -$71000.0 in 2023, then climbed by 26.76% to -$52000.0 in 2024, then surged by 973.08% to $454000.0 in 2026.
• Business Quant data shows BVS's Restructuring Costs at $454000.0 in Q1 2026, -$52000.0 in Q4 2024, and -$71000.0 in Q4 2023.